Preventive therapy with galcanezumab for two consecutive cluster bouts in patients with episodic cluster headache: an observational multicenter study

BACKGROUND: Cluster headache is a severe and disabling primary headache disorder. Galcanezumab is a monoclonal antibody against calcitonin gene-related peptide and a preventive therapy for episodic cluster headache. However, the approval and insurance coverage for episodic cluster headache differ in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Yooha, Kang, Mi-Kyoung, Moon, Heui-Soo, Kim, Byung-Kun, Cho, Soo-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566025/
https://www.ncbi.nlm.nih.gov/pubmed/37817084
http://dx.doi.org/10.1186/s10194-023-01661-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566025/
https://www.ncbi.nlm.nih.gov/pubmed/37817084
http://dx.doi.org/10.1186/s10194-023-01661-7

Ejemplares similares